NCT02242110 Brief Treatment for Trauma Nightmares in Trauma-exposed Adults With Bipolar Disorder
| NCT ID | NCT02242110 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Tulsa |
| Condition | Nightmares |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2014-06 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2014-06 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Exposure, relaxation, and rescripting therapy (ERRT) is a promising psychological intervention developed to target trauma-related nightmares and sleep disturbances. Though further evidence is needed, ERRT has shown strong support in reducing the number and intensity of nightmares, as well as improving overall sleep quality in both civilian and veteran samples. This study will assess the efficacy in individuals diagnosed with bipolar disorder.
Eligibility Criteria
Inclusion Criteria: * Nightmares at least once per week for the past month * Formal diagnosis of Bipolar disorder (I or II) * Exposure to traumatic event (1+ months ago) * Stable on bipolar medication for at least 2 months Exclusion Criteria: * A traumatic event within the last month * Intellectual disability * Current or recent mania/hypomania within the last 3 months * Suicide attempt or hospitalization within the last 3 months * Current or untreated substance use disorder within the past 6 months
Contact & Investigator
Joanne L Davis, PhD
PRINCIPAL INVESTIGATOR
University of Tulsa
Frequently Asked Questions
Who can join the NCT02242110 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Nightmares. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02242110 currently recruiting?
Yes, NCT02242110 is actively recruiting participants. Contact the research team at joanne-davis@utulsa.edu for enrollment information.
Where is the NCT02242110 trial being conducted?
This trial is being conducted at Tulsa, United States.
Who is sponsoring the NCT02242110 clinical trial?
NCT02242110 is sponsored by University of Tulsa. The principal investigator is Joanne L Davis, PhD at University of Tulsa. The trial plans to enroll 20 participants.